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IDENTIFYING PREDICTORS OF HIV PATIENTS’ SATISFACTION WITH
MAIL-ORDER AND COMMUNITY PHARMACY SERVICES
Ramasamy A, Pinto SL, Sahloff EG
University of Toledo, Toledo, OH, USA
OBJECTIVES: To determine: 1) the satisfaction of HIV/AIDS patients with services 
provided in a community vs. mail-order pharmacy; 2) the factors predicting patient
satisfaction with services provided in a community and mail-order pharmacy. 
METHODS: A prospective, cross-sectional study using a convenience sample of HIV-
infected patients receiving care at the HIV clinic at The University of Toledo Medical 
Center. Patients received their HIV medications from a mail-order pharmacy and
medication for their other comorbid conditions were received from an independent
and/or chain pharmacy. The survey instrument used for data collection was developed
from a previously validated questionnaire. SPSS v16 was used to analyze the data. 
Satisfaction was measured using Likert scale with 1 being “strongly disagree” and 5
being “strongly agree”. Exploratory factor analysis resulted in a two factor solution:
Factor 1 and 2 were named as “satisfaction with the efﬁ cient functioning of the 
pharmacy” and “satisfaction with the managing therapy role of the pharmacist” 
respectively. Multiple linear regression was used to identify the predictors of patient
satisfaction. RESULTS: One hundred and seventy eight surveys were returned. Patients 
indicated higher satisfaction with independent pharmacy services (satisfaction score
of 5) compared to chain (3.5) and mail order (3.3) pharmacies. Patients who missed
their dose due to the delay in receiving medications indicated lower satisfaction with 
mail order pharmacy (beta  -0.737, p  0.000). Further, the delay in ﬁ lling prescrip-
tions after the doctor changed their medication (beta  -0.968, p  0.017) and 
unscheduled doctor’s visits (beta  -0.835, p  0.011) affected patient satisfaction with
independent pharmacy. Unscheduled emergency room (ER) visits (beta  -0.598, p 
0.007) affected patient satisfaction with chain pharmacy. CONCLUSIONS: Results 
indicate that patients are more satisﬁ ed with the services provided at independent and 
chain pharmacies than the mail order pharmacy. This study identiﬁ ed issues that need 
to be addressed in order to enhance patient satisfaction with pharmacy services.
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EMPLOYEES’ WILLINGNESS TO PAY FOR INFLUENZA VACCINATION 
OF HOUSEHOLD MEMBERS – RESULTS FROM THE CHILD AND
HOUSEHOLD INFLUENZA-ILLNESS AND EMPLOYEE FUNCTION 
(CHIEF) STUDY
Rousculp MD1, Palmer L2, Johnston S3, Mahadevia PJ1, Nichol KL4
1MedImmune, Inc., Gaithersburg, MD, USA, 2Thomson Reuters, Ann Arbor, MI, USA, 
3Thomson Healthcare, Inc, Washington, DC, USA, 4Veterans Affairs Medical Center, 
Minneapolis, MN, USA
OBJECTIVES: Quantify employees’ willingness-to-pay (WTP) for prevention of per-
sonal and household member (HHM) inﬂ uenza-like illness (ILI) and evaluate if WTP 
varies by child vs. adult, prior season ILI, and vaccination beliefs. METHODS: The
CHIEF Study was a prospective cohort study of 2,295 U.S. employees with children 
among three Fortune 500 companies. Personal and HHM-ILI was self-reported 
monthly between 11/07–4/08. The WTP for ILI prevention for employees, adult- 
and child-HHMs, personal and HHM inﬂ uenza vaccination status, and reasons for 
vaccination/non-vaccination were captured. RESULTS: For employees with complete 
monthly survey data (n  1,990), results show a mean WTP for ILI-prevention of 
$72.00 (self), $81.94 (adult-HHM), and $140.49 (child-HHM). Employee WPT for 
ILI prevention was signiﬁ cantly different for adult-HHMs vs. child-HHMs (p  0.001). 
Employee WTP for ILI prevention for those who recently experienced ILI was $71.45 
(self), $80.98 (adult-HHM), and $143.93 (child-HHM); WTP was $72.32 (self),
$82.50 (adult-HHM), and $135.38 (child-HHM) for those not reporting ILI. In
comparing the vaccinated vs. non-vaccinated cohorts, WTP to prevent ILI was signiﬁ -
cantly higher among vaccinated employees than non-vaccinated ($86.13 vs. $62.99,
respectively; p  0.003). Employees with q1 vaccinated child reported higher WTP to 
prevent child-HHM ILI than employees without vaccinated children ($190.06 vs. 
$116.58, respectively; p  0.002). Differences in WTP for vaccinated and non-
vaccinated adult-HHM were not signiﬁ cant. Belief that vaccination is an important 
part of healthy lifestyle and that vaccination is effective was associated with higher
WTP, while reporting cost as barrier to vaccination was associated with a lower WTP 
for personal and child-HHM ILI-prevention. CONCLUSIONS: Employees expressed 
a high WTP for inﬂ uenza prevention, especially for child-HHM. Recent history of ILI
did not change employees’ WTP but belief in inﬂ uenza prevention did. Strategies to 
improve vaccine coverage should focus on the value of inﬂ uenza prevention.
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EVALUATING SOCIETAL PREFERENCES FOR THE HUMAN
PAPILLOMAVIRUS VACCINES USING DISCRETE CHOICE EXPERIMENT
Oteng B1, Marra CA1, Lynd LD1, Marra F2
1University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, 
VAncouver, BC, Canada
OBJECTIVES: Cervical cancer (CC) and genital warts (GW) are diseases associated 
with HPV infections. Two vaccines have been developed for the prevention of HPV 
infections. A quadrivalent vaccine which contains HPV types 6, 11, 16 and 18 and
prevents both cervical cancer and genital warts and a bivalent vaccine (HPV types 16 
and 18) which prevents only cervical cancer. The aim of this study was to determine 
public preferences for the two different vaccine characteristics and frequency of testing
for Pap screening. METHODS: Participants from across Canada completed the 
choice-based questionnaire for the following attributes: risk of cervical cancer and 
genital warts, frequency of Pap smear testing, need for a booster dose, target group 
(girls only or girls and boys), frequency of side effects and cost. Conditional logistic 
regression was used to determine the relative preferences and the willingness-to-pay
(WTP) for each component in the vaccination strategy. RESULTS: Of the 328 respon-
dents, 51% were between the ages of 36–55 years, 58% were females, 46% had chil-
dren, and 29% had some community college. With respect to HPV vaccination, 86% 
had fully vaccinated their children and 68% were considering the HPV vaccine.
Respondents had a strong preference for a vaccine which provided protection against
GW. Respondents also had a preference to avoid a yearly Pap smear and most pre-
ferred testing every 3 years. Respondents preferred lifetime protection from HPV
vaccine and thus valued a booster dose every 10 years for their children. To reduce
the risk of CC and GW by 1%, respondents had a WTP of $39 and $36, respectively
for the vaccine. Respondents also preferred to vaccinate both boys and girls at a WTP
of $23. CONCLUSIONS: An HPV vaccine which provides protection against both
CC and GW, and vaccinating both boys and girls appeared to be strongly associated 
with respondent preferences.
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IMPROVING PHYSICIAN ADHERENCE TO GUIDELINES FOR DRUG
THERAPY: A RANDOMIZED CONTROLLED TRIAL OF EDUCATIONAL
INTERVENTIONS IN A MANAGED CARE SETTING IN ISRAEL
Kahan NR1, Kahan E2, Waitman DA1, Vardy DA1, Kitai E1, Chinitz DP3
1Leumit Health Fund, Tel-Aviv, Israel, 2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 
Israel, 3The Hebrew University of Jerusalem School of Public Health, Jerusalem, Israel
OBJECTIVES: Although clinical-practice-guidelines (CPGs) are implemented to 
improve the quality, efﬁ ciency, and consistency of health care, CPGs generally have 
limited effect in changing physician behavior. The objective of this study was to design, 
implement and evaluate an intervention for CPG implementation tailored to ﬁ t the 
organizational culture of an Israeli HMO. The test-case for this intervention was
implementation of CPGs for empiric antibiotic treatment of uncomplicated cystitis in 
adult women. METHODS: Personalized feedback containing data on individual pre-
scribing patterns sent by specialists in family practice and infectious diseases, and an 
academic lecture at a HMO sponsored conference were designed. These two educa-
tional interventions were implemented both separately and combined amongst HMO
primary care physicians. Steps were taken to ensure that the interventions were carried 
out with an eye to preserving the atmosphere of mutual professional respect between
HMO management and the physicians. The objective of the interventions was to
improve rate of prescribing of the ﬁ rst line drug nitrofurantoin or adherence to the 
three day recommended duration of treatment with oﬂ oxacin if prescribed. Pre and
Post intervention prescribing patterns in the three intervention groups and the control 
group were calculated. RESULTS: The lecture alone improved rate of adherence to 
the guidelines by ^7% (95% CI  1.3, 13.6), but a short duration of effect was 
observed. Feedback alone was sufﬁ cient to improve the rate of adherence to the 
guidelines by 19.4% (95% CI  16.7, 22.1) and was not observed to be inferior to
the combined intervention strategy. No signiﬁ cant change in prescribing patterns was
observed amongst physicians in the control group. CONCLUSIONS: This model may 
be useful for promoting other evidence-based messages via a mechanism for presenting
individual data to physicians while being sensitive to professional respect.
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RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS, DENIALS, AND
HOSPITALIZATIONS IN A COMMERCIALLY INSURED POPULATION
Bowen KL1, Jay M2
1Excellus BlueCross BlueShield, Rochester, NY, USA, 2Excellus BlueCross BlueShield, 
Williamsville, NY, USA
OBJECTIVES: To estimate the proportion of a population receiving RSV prophylaxis, 
proportion selected for prophylaxis but not meeting American Academy of Pediatrics
guidelines (AAP), and fractions of these and the total population hospitalized for RSV
bronchiolitis or pneumonia. METHODS: The study sample consists of all neonates 
born into a geographically deﬁ ned subset of a commercially insured population who
had medical claims extending from birth through one or two of ﬁ ve RSV seasons
between Fall 2003 and Spring 2008. An AAP-based coverage policy was in effect 
throughout but prior authorization (PA) required only during the latest seasons. 
Patients with/without claims for prophylaxis and/or RSV-coded hospitalization are 
categorized by birth weight, age, and information from PA and claims. RESULTS: A 
total of 44841 neonates were followed through one (10.6%) or two (89.4%) seasons
(79253 child-seasons of administrative claims). Counting each once per season, there 
were 939 cases that received RSV prophylaxis of which 51% had PA approval and
49% had not required PA. Another 216 cases were denied coverage after PA. Addi-
tional patients had partial denials for requests for palivizumab starting before or 
continuing after the RSV season. There were 481 hospitalizations coded for RSV: 20
cases that received palivizumab, 3 of the denied cases, plus another 458 that had not 
received prophylaxis (of which 93% had normal and 5% moderately low birth weight,
and none had claims evidence of chronic lung or congential heart disease). Estimated
population RSV hospitalization rate per season was 18.4, 3.6, and 1.7 per thousand 
age  6, 6–12, and 12–24 months, respectively. CONCLUSIONS: In this population, 
a substantial fraction of patients selected for palivizumab, and most patients hospital-
ized for RSV, do not meet AAP criteria for prophylaxis.
